Which funds bought or sold BKR in Q3 2026?
Baker Hughes Company. 4 funds bought, 5 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$845M.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- Millennium+$208M
- Holocene+$167M
- Ameriprise+$159M
- ExodusPointNEW+$46M
- Capital World−$1.0B
- State Street−$188M
- Dodge & Cox−$108M
- Renaissance−$76M
- GlenviewOUT−$27M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (4)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Millennium Quant & multi-strategy | Added+366.6% | +$208M | $264M |
| Holocene Hedge fund | Added+850.5% | +$167M | $186M |
| Ameriprise Asset manager | Added+93.8% | +$159M | $329M |
| ExodusPoint Quant & multi-strategy | New | +$46M | $46M |
Sold (5)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Capital World Asset manager | Trimmed-39.7% | −$1.0B | $1.6B |
| State Street Index giant | Trimmed-5.3% | −$188M | $3.4B |
| Dodge & Cox Value investor | Trimmed-5.6% | −$108M | $1.8B |
| Renaissance Quant & multi-strategy | Trimmed-84.6% | −$76M | $14M |
| Glenview Hedge fund | Sold out | −$27M | — |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.